Eli Lilly and Company, along with partner institutions in the US and United Kingdom, describe how short-term pharmacologic ...
The Food and Drug Administration is set to treat the application under its priority program to accelerate the review of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback